HC Wainwright reissued their buy rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report issued on Thursday morning, Marketbeat Ratings reports. They currently have a $22.00 price objective on the stock. A number of other research analysts also recently issued reports on the stock. Wedbush started coverage on shares of Immunic in […]

HC Wainwright restated their buy rating on shares of GRI Bio (NASDAQ:GRI – Free Report) in a research report sent to investors on Thursday morning,Benzinga reports. The firm currently has a $10.00 target price on the stock. Several other equities research analysts have also recently commented on the stock. Weiss Ratings reaffirmed a “sell (e+)” […]

HC Wainwright reissued their buy rating on shares of BridgeBio Pharma (NASDAQ:BBIO – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $120.00 price objective on the stock. A number of other equities research analysts also recently issued reports on BBIO. Bank of America increased their price objective on […]

Wedbush restated their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a research report released on Thursday,Benzinga reports. The brokerage currently has a $45.00 price objective on the stock. Other analysts have also recently issued research reports about the company. HC Wainwright reaffirmed a “buy” rating and issued a $22.00 price target […]